- Home
- LMND vs XENE Comparison
LMND vs XENE Comparison
Compare LMND & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LMND | XENE |
|---|---|---|
| Founded | 2015 | 1996 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 3.7B |
| IPO Year | 2020 | 2014 |
Fundamental Metrics
Financial Performance| Metric | LMND | XENE |
|---|---|---|
| Price | $43.88 | $33.59 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 11 | 19 |
| Target Price | $58.44 | ★ $72.43 |
| AVG Volume (30 Days) | 1.1M | ★ 2.1M |
| Earning Date | 11-04-2026 | 11-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 21.40 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $737,900,000.00 | $311,000.00 |
| Revenue This Year | $65.04 | N/A |
| Revenue Next Year | $34.88 | $2,045.70 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 40.15 | N/A |
| 52 Week Low | $42.70 | $33.38 |
| 52 Week High | $99.90 | $72.66 |
Technical Indicators
Market Signals| Indicator | LMND | XENE |
|---|---|---|
| Relative Strength Index (RSI) | 37.55 | 21.03 |
| Support Level | $43.28 | N/A |
| Resistance Level | $47.62 | $43.68 |
| Average True Range (ATR) | 1.60 | 1.18 |
| MACD | 0.09 | 0.45 |
| Stochastic Oscillator | 21.95 | 5.50 |
Price Performance
Historical ComparisonAbout LMND Lemonade Inc.
Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes. The company is using technology, data, artificial intelligence, contemporary design, and social impact to deliver delightful and affordable insurances. The Company operates in one report segment providing personal property and casualty insurance products within the United States and Europe, including the UK.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.